Price
CHART BY
Frequently asked questions
What is Personalis's market capitalization?
The market capitalization of Personalis is $334.86M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Personalis?
Personalis's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.677. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Personalis's stock?
Currently, 6 analysts cover Personalis's stock, with a consensus target price of $7.45. Analyst ratings provide insights into the stock's expected performance.
What is Personalis's revenue over the trailing twelve months?
Over the trailing twelve months, Personalis reported a revenue of $87.49M.
What is the EBITDA for Personalis?
Personalis's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$58.78M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Personalis?
Personalis has a free cash flow of -$54.65M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Personalis have, and what sector and industry does it belong to?
Personalis employs approximately 225 people. It operates in the Health Care sector, specifically within the Medical/ Nursing Services industry.
What is the free float of Personalis's shares?
The free float of Personalis is 35.33M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $334.86M
- EPS (TTM)
- -$1.677
- Free Float
- 35.33M
- Revenue (TTM)
- $87.49M
- EBITDA (TTM)
- -$58.78M
- Free Cashflow (TTM)
- -$54.65M
Pricing
- 1D span
- $4.715$5.609
- 52W span
- $1.14$7.20
Analyst Ratings
The price target is $7.45 and the stock is covered by 6 analysts.
Buy
5
Hold
1
Sell
0
Information
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.
- Employees
- 225
- Industries
- Medical/ Nursing Services
- Sector
- Health Care
Identifier
- ISIN
- US71535D1063
- Primary Ticker
- PSNL
Knockouts
Finance data from FactSet